Detailansicht

Wissensnetz

Person

Isabel Rauscher (1983-)

Ärztin

Name	Isabel Rauscher
Zeit	1983- (Lebensdaten)
Ort	Ulm (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med. (Techn. Univ. München) (2011)
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Habil. Fach Nuklearmedizin an der Techn. Univ. München
Datensatztyp	Person
GND-Nummer	1211041344
Datensatz-ID	1211041344
Beteiligt an alle anzeigen Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma The added value of PSMA PET/MR radiomics for prostate cancer staging Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients 68Ga-PSMA-11-PET/mpMRT zur Lokaldetektion des primären Prostatakarzinoms bei Männern mit negativer Vorbiopsie [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model Hybridbildgebung beim Prostatakarzinom : Status quo und zukünftige Entwicklungen [99mTc]Tc-PSMA-I&S: Anwendung zur Radioguided Surgery beim rezidivierten Prostatakarzinom 68Ga-PSMA-11 PET/mpMRT zur Lokaldetektion des primären Prostatakarzinom bei Männern mit negativer Vorbiopsie Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis Molekulare Bildgebung und Therapie des Prostatakarzinoms Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy Multiparametric 18F–FDG PET/MR follow-up in a patient with autoimmune pancreatitis Prospective head-to-head comparison of 11C-choline-PET/MR and 11C-choline-PET/CT for restaging of biochemical recurrent prostate cancer Revolution in der bildgebenden Diagnostik des Prostatakarzinoms: die PSMA-Liganden PET 111In-PSMA-radioguided surgery beim oligometastasierten Prostatakarzinomrezidiv 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report Visualization of stress fractures of the foot using PET-MRI: a feasibility study Meniscal measurements of T1ρ [T 1 rho] and T2 at MR imaging in healthy subjects and patients with osteoarthritis Meniscal Measurements of T1Ρ and T2 at MR Imaging in Healthy Subjects and Patients with Osteoarthritis

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Isabel Rauscher (1983-)

Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics

Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

The added value of PSMA PET/MR radiomics for prostate cancer staging

Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients

68Ga-PSMA-11-PET/mpMRT zur Lokaldetektion des primären Prostatakarzinoms bei Männern mit negativer Vorbiopsie

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients

Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model

Hybridbildgebung beim Prostatakarzinom : Status quo und zukünftige Entwicklungen

[99mTc]Tc-PSMA-I&S: Anwendung zur Radioguided Surgery beim rezidivierten Prostatakarzinom

68Ga-PSMA-11 PET/mpMRT zur Lokaldetektion des primären Prostatakarzinom bei Männern mit negativer Vorbiopsie

Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis

Molekulare Bildgebung und Therapie des Prostatakarzinoms

Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands

Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy

Multiparametric 18F–FDG PET/MR follow-up in a patient with autoimmune pancreatitis

Prospective head-to-head comparison of 11C-choline-PET/MR and 11C-choline-PET/CT for restaging of biochemical recurrent prostate cancer

Revolution in der bildgebenden Diagnostik des Prostatakarzinoms: die PSMA-Liganden PET

111In-PSMA-radioguided surgery beim oligometastasierten Prostatakarzinomrezidiv

68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

Visualization of stress fractures of the foot using PET-MRI: a feasibility study

Meniscal measurements of T1ρ [T 1 rho] and T2 at MR imaging in healthy subjects and patients with osteoarthritis

Meniscal Measurements of T1Ρ and T2 at MR Imaging in Healthy Subjects and Patients with Osteoarthritis